Gastro Broadcast

Dr. Lisa Mathew interviews Vetri Venthan Elango and Dr. Renu Dhanasekaran, the founders of Arithmedics, a company that uses generative AI and data intelligence to reduce administrative time and costs for providers.

Arithmedics uses generative AI and data intelligence to reduce billing mistakes and claim denials. Its software generates and explains codes to streamline the billing process and uses data from completed claims to reduce future denials.

Join Dr. Mathew, Dr. Elango and Dr. Dhanasekaran as they discuss what physicians need to understand about implementing AI platforms for administrative tasks such as billing and coding.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 76, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Gary Trendel, vice president of Endoscopy Solutions Ecosystem and Dr. Ruhy Patel, Medical and Scientific Affairs lead for the Endoscopy Solutions Ecosystem and Digital Units at Olympus.

Odin Medical, an Olympus company, recently received 510K clearance from the U.S. Food and Drug Administration for the first cloud-based Artificial Intelligence technology designed to assist gastroenterologists in detecting colorectal polyps during colonoscopy procedures.

The CADDIE, or computer-aided detection (CADe) device, works by analyzing colonoscopy video in real-time and using visual markers to alert the endoscopist to the potential presence of polyps.

A prospective, multi-center randomized controlled trial successfully demonstrated the efficacy and safety of the CADDIE device, underscoring its potential to enhance detection capabilities and patient care without increasing procedural risks or duration.

Join Dr. Mathew, Mr. Trendel, and Dr. Patel as they discuss the potential for AI in improving patient care, and what independent GI physicians should understand about AI platforms that assist in detecting polyps during colonoscopy.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 75, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Jeff Glueck, co-founder and CEO of Salvo Health, a technology company that partners with GI practices to support patients with chronic GI conditions through a virtual clinic experience using a multi-disciplinary care team.

Salvo Health's framework seeks to restore balance and improve chronic symptoms by considering the interconnected roles that the mind, body and gut play in a person's health.

Join Lisa and Jeff as they discuss what GI physicians should consider in partnering with technology platforms that provide cross-functional care to their patients.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 74, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Dr. Vijay Yajnik, vice president and head of U.S. Medical, Gastroenterology, at Takeda about how the prevalence of eosinophilic esophagitis (EoE) is increasing, and evidence is growing that EoE is not a rare disease, but an underdiagnosed one.

Approximately one in 2000 people in the U.S. live with EoE, and the incidence and prevalence of eosinophilic esophagitis have steadily increased over time.

Join Dr. Mathew and Dr. Yajnik as they explore progress that has been made in diagnosing and treating EoE, and some recent studies that could influence patient care.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 73, presented by TissueCypher from Castle Biosciences

Dr. Michael Weinstein interviews Dr. Ali Rezaie, a GI physician-scientist who specializes in microbiome research and gastrointestinal motility disorders.

His recent study, which won an award at ACG, showed that a new elemental diet from mBIOTA Labs can significantly improve patient compliance.

The study assessed mBIOTA Elemental, a palatable elemental diet designed to address the barriers of poor taste and low adherence associated with traditional elemental diets.

Participants using mBIOTA Elemental had complete compliance throughout the two-week therapy, a critical outcome when managing gastrointestinal disorders such as Small Intestinal Bacterial Overgrowth (SIBO), Inflammatory Bowel Disease (IBD), and other complex GI conditions.

Join Dr. Weinstein and Dr. Rezai as they explore how new innovations in elemental diets can help support patients with specific GI conditions and needs.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 72, presented by TissueCypher from Castle Biosciences

Dr. Michael Weinstein interviews Dr. Larry Kosinski about new data from SonarMD describing the association between anxiety and increased risk for flares and higher disease severity in inflammatory bowel disease (IBD), and emphasizing the importance of integrating mental health support within value-based care models for IBD management.

According to the study, patients with anxiety symptoms were significantly more likely to have high disease severity, and over a six-month follow-up, patients with anxiety exhibited a nearly doubled flare rate.

The study suggests that mental health factors like anxiety play a critical role in the clinical course of IBD and that by identifying and addressing psychological contributors, value-based care models can be refined to better support patients with chronic digestive diseases.

Join Dr. Weinstein and Dr. Kosinski as they explore the importance of a multidisciplinary approach to IBD management and what GI physicians can do to ensure that their patients have the resources they need.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 71, presented by TissueCypher from Castle Biosciences

Host Dr. Lisa Mathew interviews Kathleen Teixeira, vice president of public policy and advocacy for the American Gastroenterological Association.

Lisa and Kathleen discuss what policies will be in play in 2025 and how GI physicians can get involved to advocate for their patients and their practices.

Join Lisa and Kathleen as they explore how physicians can get involved in shaping the policies that will affect patient care and practice management with the new Congress and Administration.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 70, presented by TissueCypher from Castle Biosciences

Kevin Harlen interviews Laura Wingate, chief education, support, and advocacy officer with the Crohn's & Colitis Foundation about a recent survey which shows that more than 40 percent of patients with inflammatory bowel disease (IBD) have made significant financial trade-offs to afford their healthcare.

The survey, published in Inflammatory Bowel Diseases, included responses from more than 2,200 IBD patients and caregivers, who highlighted persistent challenges.

Among respondents, 30 percent reported giving up vacations or major household purchases, 22 percent increased their credit card debt, and 21 percent cut back on essential items such as food, clothing, or basic household items.

Join Kevin and Laura as they explore what can done to ensure that IBD patients can access the medications they need without undue financial hardship.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 69, presented by TissueCypher from Castle Biosciences

Dr. Fred Rosenberg interviews Dr. Ruchi Mathur, director of the Diabetes Program in the Division of Endocrinology, Diabetes and Metabolism and an endocrinologist at the Weight Loss Center, at Cedars-Sinai.

Cedars-Sinai recently released a study which found that patients who take a class of widely prescribed medications (GLP-1) to manage diabetes and obesity may require extra preparations before undergoing upper endoscopy procedures.

Join Dr. Rosenberg and Dr. Mathur as they explore how gastroenterologists can advise patients who take GLP-1 medications when preparing for endoscopic procedures, to have the best results.

---

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 68

Dr. Naresh Gunaratnam interviews Kim Beall, co-founder and managing director of Nutritional Therapy for IBD and Dr. Ashwin Ananthakrishnan, who is the Director of the Massachusetts General Hospital Crohn's and Colitis Center about their work to advance evidence-based nutrition as part of IBD treatment plans.

When nutritional strategies are used in combination with medications, additional pathways are engaged to improve symptoms, quality of life and aid tissue healing.

When patients are able to access evidence-based nutritional therapy under the guidance of a healthcare providers it can them find foods to restore a healthy relationship with food and work their way back to a well-balanced diet of healthy, foods while at the same time feeling well again.

Join Dr. Gunaratnam, Ms. Beall and Dr. Ananthakrishnan as they explore how Nutritional Therapy for IBD works to inform, support, and empower patients and clinicians by providing education and essential tools and resources to utilize nutritional therapy alongside medication.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 67, presented by TissueCypher from Castle Biosciences